168 related articles for article (PubMed ID: 9133408)
1. Dissociation of tolerance and dependence for opioid peripheral antinociception in rats.
Aley KO; Levine JD
J Neurosci; 1997 May; 17(10):3907-12. PubMed ID: 9133408
[TBL] [Abstract][Full Text] [Related]
2. Different mechanisms mediate development and expression of tolerance and dependence for peripheral mu-opioid antinociception in rat.
Aley KO; Levine JD
J Neurosci; 1997 Oct; 17(20):8018-23. PubMed ID: 9315920
[TBL] [Abstract][Full Text] [Related]
3. Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal.
Aley KO; Levine JD
J Neurosci; 1997 Jan; 17(2):735-44. PubMed ID: 8987795
[TBL] [Abstract][Full Text] [Related]
4. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal.
Aley KO; Green PG; Levine JD
J Neurosci; 1995 Dec; 15(12):8031-8. PubMed ID: 8613740
[TBL] [Abstract][Full Text] [Related]
5. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
Capasso A; Sorrentino L; Pinto A
Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
[TBL] [Abstract][Full Text] [Related]
6. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC.
Kramer HK; Simon EJ
J Neurochem; 1999 Feb; 72(2):594-604. PubMed ID: 9930731
[TBL] [Abstract][Full Text] [Related]
7. Mu-opioid agonist enhancement of prostaglandin-induced hyperalgesia in the rat: a G-protein beta gamma subunit-mediated effect?
Khasar SG; Wang JF; Taiwo YO; Heller PH; Green PG; Levine JD
Neuroscience; 1995 Jul; 67(1):189-95. PubMed ID: 7477899
[TBL] [Abstract][Full Text] [Related]
8. DAMGO inhibits prostaglandin E2-induced potentiation of a TTX-resistant Na+ current in rat sensory neurons in vitro.
Gold MS; Levine JD
Neurosci Lett; 1996 Jul; 212(2):83-6. PubMed ID: 8832644
[TBL] [Abstract][Full Text] [Related]
9. Opioidergic modulation of voltage-activated K+ currents in magnocellular neurons of the supraoptic nucleus in rat.
Müller W; Hallermann S; Swandulla D
J Neurophysiol; 1999 Apr; 81(4):1617-25. PubMed ID: 10200198
[TBL] [Abstract][Full Text] [Related]
10. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat.
Miaskowski C; Taiwo YO; Levine JD
Eur J Pharmacol; 1991 Dec; 205(3):247-52. PubMed ID: 1667910
[TBL] [Abstract][Full Text] [Related]
11. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
13. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
14. Effects of mu and delta opioid agonists and antagonists on affective vocal and reflexive pain responses during social stress in rats.
Vivian JA; Miczek KA
Psychopharmacology (Berl); 1998 Oct; 139(4):364-75. PubMed ID: 9809857
[TBL] [Abstract][Full Text] [Related]
15. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by mu-opioid agonists.
Kramer HK; Simon EJ
J Neurochem; 1999 Feb; 72(2):585-93. PubMed ID: 9930730
[TBL] [Abstract][Full Text] [Related]
16. Reduction in [D-Ala2, NMePhe4, Gly-ol5]enkephalin-induced peripheral antinociception in diabetic rats: the role of the L-arginine/nitric oxide/cyclic guanosine monophosphate pathway.
Tasatargil A; Sadan G
Anesth Analg; 2004 Jan; 98(1):185-192. PubMed ID: 14693616
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
Machelska H; Labuz D; Przewłocki R; Przewłocka B
J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
[TBL] [Abstract][Full Text] [Related]
18. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive tolerance to the mu-opioid agonist DAMGO is dose-dependently reduced by MK-801 in rats.
Mao J; Price DD; Lu J; Mayer DJ
Neurosci Lett; 1998 Jul; 250(3):193-6. PubMed ID: 9708865
[TBL] [Abstract][Full Text] [Related]
20. mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat.
Schmidt BL; Tambeli CH; Levine JD; Gear RW
Eur J Neurosci; 2002 Mar; 15(5):861-8. PubMed ID: 11906528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]